Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Nozinan is not indicated for the treatment of patients with dementia-related psychosis.

Contraindicated in cases of coma or CNS depression due to alcohol, hypnotics, analgesics or narcotics; also in patients with blood dyscrasia, hepatic problems or a sensitivity to phenothiazines.

Not available in the USA.